Allowing subsidies, IP coverage for off-label cancer drugs will drive up costs: MOH (ST, 18/06/2022)
One way of paying for these off-label cancer drugs is to have a Critical Illness plan. Depending on your type of plans, it will pay the benefit in a lump sum at the diagnosis of the critical illnesses at Early, Intermediate and/or Advanced stage.
You can use this lump sum to pay for the off-label cancer drugs or other alternative treatments that you wish to explore.
My IFA@Sg 